Sep 9, 2016 ... Pharmaceutical companies recently achieved a significant legal victory in a product liability suit involving amiodarone (brand name Cordarone®) that plaintiff filed in the United States District Court for the Eastern District of North Carolina. See Sara Perdue, as Executor of the Estate of Marjorie Newton v.
In February 2016, Pfizer subsidiary Wyeth agreed in principle to pay $784.6 million to the U.S.. ... USA, ex. rel., Lauren Kieff, et al. v. ... Carolyn Ellis of the New York State Attorney General's Office and Steven Sharobem of the Attorney General's Office for the Commonwealth of Massachusetts led the states' efforts in this case.
Nov 7, 2008 ... Gordon & Rees, Stuart M. Gordon, James R. Reilly, Fletcher C. Alford, San Francisco, Davis Graham & Stubbs, Jeffrey R. Pilkington, for Respondent Wyeth, Inc. Hanson Bridgett Marcus Vlahos & Rudy, Merton A. Howard, Jill N. Cartwright, San Francisco, for Respondent Pliva, Inc. Tucker Ellis & West, ...
In Torkie-Tork v. Wyeth, 739 F. Supp. 2d 887, 890–91 (E.D. Va. 2010), an. HRT personal injury case similar to the one at the bar, a Virginia resident plaintiff alleged that. Prempro caused her breast cancer, but presiding Judge T.S. Ellis, III explained that § 8.01-. 243(A)'s two-year limitations period governed plaintiff's ...
Apr 27, 2016 ... Wyeth Pharmaceuticals, Inc., Civ. No. 03-cv-12366, and U.S., , et al., ex rel. William St. John LaCorte v. Wyeth, Civ. No. 06-cv-11724 which were filed in the ... Senior Counsel Carolyn T. Ellis led a multi-state team that litigated the case and negotiated the settlement with Wyeth and Pfizer for the States.
Dec 4, 2015 ... MEMORANDUM DOUGLAS P. WOODLOCK District Judge. The government seeks damages in these civil cases under the Federal False Claims Act... 20151207d59.
Feb 20, 2017 ... It did, but while it had cases discussing nurses: Yes: Ellis v. C.R. Bard, Inc., 311 F. 3d 1272, 1281 (11th Cir. 2002) (applying Georgia law); Walker v. Merck & Co., 648 F. Supp. 931, 934 (M.D. Ga. 1986), aff'd without op., 831 F.2d 1069 (11th Cir. 1987); Wyeth-Ayerst Laboratories Co. v. Medrano, 28 S.W.3d 87, ...
Nov 10, 2014 ... acknowledged that plaintiffs' alleged fraud and failure-to-warn claims were preempted by FIFRA, since they were “premised on common-law rules that qualify as 'requirements for labeling or packaging'” that paralleled FIFRA and would require a product label change. Id. at 446. However, the Court found ...
Jul 6, 2007 ... 1991); Niemiera v. Schneider, 555 A.2d 1112, 1117 (N.J. 1989); and White v. Wyeth Laboratories, Inc., 533 N.E.2d 748, 755 (Ohio 1988). So we like to think ... The Rule's consistency with overarching federal regulation of prescription medical products has been repeatedly recognized. E.g., Ellis v. C.R. Bard.